Den europeiske union - estisk - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfaat - cushingi sündroom - kortikosteroidid süsteemseks kasutamiseks - isturisa on näidustatud ravi sisemise cushingi sündroom täiskasvanutel.

Den europeiske union - estisk - EMA (European Medicines Agency)

tetris pharma b.v - glucagon - diabeet mellitus - pankrease hormoonid, hormoonid glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Den europeiske union - estisk - EMA (European Medicines Agency)

vetoquinol - triptorelin acetate - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Den europeiske union - estisk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Estland - estisk - Ravimiamet

laboratorios calier s.a. - folliikulit stimuleeriv hormoon+lutropiin - süstelahuse pulber ja lahusti - 500rÜ+500rÜ 1tk

Den europeiske union - estisk - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemilised preparaadid - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Den europeiske union - estisk - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Estland - estisk - Ravimiamet

interfish halszaporito es tanacsado kft. - gonadotropiini vabastava hormooni analoog+metoklopramiid - süste-/infusioonilahuse pulber - 25mcg+20mg 1tk 100tk 1tk

Den europeiske union - estisk - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - eesnäärmevähk - endokriinset ravi - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Den europeiske union - estisk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.